Your browser doesn't support javascript.
loading
The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline.
Rochwerg, Bram; Einav, Sharon; Chaudhuri, Dipayan; Mancebo, Jordi; Mauri, Tommaso; Helviz, Yigal; Goligher, Ewan C; Jaber, Samir; Ricard, Jean-Damien; Rittayamai, Nuttapol; Roca, Oriol; Antonelli, Massimo; Maggiore, Salvatore Maurizio; Demoule, Alexandre; Hodgson, Carol L; Mercat, Alain; Wilcox, M Elizabeth; Granton, David; Wang, Dominic; Azoulay, Elie; Ouanes-Besbes, Lamia; Cinnella, Gilda; Rauseo, Michela; Carvalho, Carlos; Dessap-Mekontso, Armand; Fraser, John; Frat, Jean-Pierre; Gomersall, Charles; Grasselli, Giacomo; Hernandez, Gonzalo; Jog, Sameer; Pesenti, Antonio; Riviello, Elisabeth D; Slutsky, Arthur S; Stapleton, Renee D; Talmor, Daniel; Thille, Arnaud W; Brochard, Laurent; Burns, Karen E A.
Afiliação
  • Rochwerg B; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Einav S; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  • Chaudhuri D; General Intensive Care Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Mancebo J; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Mauri T; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Helviz Y; Servei de Medicina Intensiva, Hospital Universitari Sant Pau, Barcelona, Spain.
  • Goligher EC; Dipartimento Di Fisopatologia Medico-Chirurgica E Dei Trapianti, Università Degli Studi Di Milano, Milan, Italy.
  • Jaber S; Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Ricard JD; General Intensive Care Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Rittayamai N; Department of Medicine, Division of Respirology, University Health Network, Toronto, Canada.
  • Roca O; Interdepartment Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
  • Antonelli M; University Hospital of Montpellier and Saint Eloi Hospital, Montpellier University, Montpellier, France.
  • Maggiore SM; Assistance Publique-Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Hôpital Louis Mourier, 92700, Colombes, France.
  • Demoule A; Université de Paris, IAME, U1137, Inserm, 75018, Paris, France.
  • Hodgson CL; Division of Respiratory Diseases and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Mercat A; Servei de Medicina Intensiva, Hospital Universitari Vall D'Hebron, Institut de Recerca Vall D'Hebron, Barcelona, Spain.
  • Wilcox ME; Ciber Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Granton D; Department of Anesthesiology Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Wang D; Istituto Di Anestesiologia E Rianimazione, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Azoulay E; University Department of Medical, Oral and Biotechnological Sciences, G. D'Annunzio University of Chieti-Pescara and Clinical, Department of Anesthesia, Critical Care and Pain Medicine, SS. Annunziata Hospital, Chieti, Italy.
  • Ouanes-Besbes L; Sorbonne Université, INSERM, UMRS1158, Neurophysiologie Respiratoire Expérimentale Et Clinique, Paris, France.
  • Cinnella G; Service de Pneumologie, Médecine Intensive Et Réanimation, Département R3S, AP-HP Sorbonne Université, Hospital Pitié-Salpêtrière, Paris, France.
  • Rauseo M; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.
  • Carvalho C; Department of Intensive Care, Alfred Health, Melbourne, Australia.
  • Dessap-Mekontso A; Département de Médecine Intensive-Réanimation, CHU D'Angers, Université D'Angers, Angers, France.
  • Fraser J; Department of Medicine, Division of Respirology, University Health Network, Toronto, Canada.
  • Frat JP; Interdepartment Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
  • Gomersall C; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Grasselli G; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Hernandez G; Service de Médecine Intensive Et Réanimation. APHP, Hôpital Saint-Louis, Université de Paris, Paris, France.
  • Jog S; Intensive Care Unit, CHU F. Bourguiba Monastir, Université de Monastir, 5000, Monastir, Tunisia.
  • Pesenti A; Research Lab, Cardiopulmonary Research in Intensive Care and Toxicology, LR12SP15, Monastir, Tunisia.
  • Riviello ED; Department of Anesthesia and Intensive Care, University of Foggia, Foggia, Italy.
  • Slutsky AS; Department of Anesthesia and Intensive Care, University of Foggia, Foggia, Italy.
  • Stapleton RD; Pulmonary Division, Hospital das Clinicas - Heart Institute (InCor), School of Medicine, University of São Paulo, São Paulo, SP, Brazil.
  • Talmor D; AP-HP; Hôpitaux universitaires Henri Mondor, Service de Médecine Intensive Réanimation, 94010, Créteil, France.
  • Thille AW; Faculté de Santé de Créteil, Université Paris Est Créteil, GRC CARMAS, 94010, Créteil, France.
  • Brochard L; Critical Care Research Group, University of Queensland, Brisbane, Australia.
  • Burns KEA; Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, Australia.
Intensive Care Med ; 46(12): 2226-2237, 2020 12.
Article em En | MEDLINE | ID: mdl-33201321
ABSTRACT

PURPOSE:

High flow nasal cannula (HFNC) is a relatively recent respiratory support technique which delivers high flow, heated and humidified controlled concentration of oxygen via the nasal route. Recently, its use has increased for a variety of clinical indications. To guide clinical practice, we developed evidence-based recommendations regarding use of HFNC in various clinical settings.

METHODS:

We formed a guideline panel composed of clinicians, methodologists and experts in respiratory medicine. Using GRADE, the panel developed recommendations for four actionable questions.

RESULTS:

The guideline panel made a strong recommendation for HFNC in hypoxemic respiratory failure compared to conventional oxygen therapy (COT) (moderate certainty), a conditional recommendation for HFNC following extubation (moderate certainty), no recommendation regarding HFNC in the peri-intubation period (moderate certainty), and a conditional recommendation for postoperative HFNC in high risk and/or obese patients following cardiac or thoracic surgery (moderate certainty).

CONCLUSIONS:

This clinical practice guideline synthesizes current best-evidence into four recommendations for HFNC use in patients with hypoxemic respiratory failure, following extubation, in the peri-intubation period, and postoperatively for bedside clinicians.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Ventilação não Invasiva Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: Intensive Care Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Ventilação não Invasiva Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: Intensive Care Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá